GNE-9815 is primarily utilized in the field of oncology research, where it serves as a potent and selective inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Its application is focused on preclinical studies to evaluate its efficacy in inhibiting tumor growth and understanding its mechanism of action in various cancer models. Researchers employ GNE-9815 to explore its potential as a therapeutic agent, particularly in cancers driven by dysregulated kinase signaling pathways. Additionally, it is used in combination studies with other anticancer agents to assess synergistic effects and enhance treatment outcomes. The compound also aids in the development of biomarkers to predict patient response and resistance mechanisms, contributing to personalized medicine approaches in oncology.